NCT06724614Phase 2, phase 3Active not recruiting

Efficacy and Safety of VDPHL01 in Males With AGA

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2026-02Estimated

Enrollment · participants480Estimated

Source updated2025-11-06Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2025-11-06 · 1 field changed

Primary completion date changed

− Before

~~Jul 2026~~

+ After

Feb 2026

Check registry source

Study details

Conditions studied

Androgenetic Alopecia; AGA; Male Pattern Baldness

Treatments or interventions studied

VDPHL01Drug
PlaceboDrug

Primary outcomes · main study measures

Read the study measures

measure: Changes in non-vellus Target Area Hair Counts (TAHC); description: Change from baseline in non-vellus TAHC using digital image analysis at Month 6.; timeFrame: Month 6; measure: Subjects Evaluation of Treatment Benefit; description: Subjects will rate their treatment benefit by responding to a hair assessment scale. The proportion of subjects by each response category will be reported at Month 6.; timeFrame: Month 6

History coverage

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

How to read this history